about
Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literatureDesign considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy.The Controversy over Generic Antiepileptic Drugs.Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?Efficacy and adverse effects of established and new antiepileptic drugs.Community pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan.Loss of seizure control associated with generic substitution of carbamazepine.Bioavailability and dissolution of proprietary and generic formulations of phenytoinDifferences between the measured and calculated free serum phenytoin concentrations in epileptic patients.Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients.Assessing bioequivalence of generic modified-release antiepileptic drugs.Experience-based teaching of therapeutics and clinical pharmacology of antiepileptic drugs. Sudden unexplained death in epilepsy: do antiepileptic drugs have a role?Comparative bioavailability of a generic phenytoin and Dilantin.Advances in the assessment of refractory epilepsy.The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.AES Position Statement on Generic Substitution of Antiepileptic Drugs.Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
P2860
Q26749431-71725622-E76A-4127-A0F2-79F67E2D184AQ30496647-A6CD8CA4-4DF3-4A36-9E26-B446A01D3F93Q34476865-F43F6563-1D6D-4230-8515-67C54F3134CEQ34614739-10F92793-83AC-4F5A-BB01-E87296826A63Q34734496-A5083ABA-78D7-468C-B9B3-7963DFCD76B4Q35741403-D15DB410-F326-46CF-8996-FA28414E5CC0Q36235675-3886C4A3-5283-44BC-BE26-180B38902129Q36966092-4E28E456-A46F-4C94-8A13-56F6BA2D7548Q37315030-E668103F-9C7D-42E9-BAEA-96C1F2ECEB8DQ37824886-43812E97-06B0-4D59-9CF4-F3009053348FQ39887948-2308EA70-3380-4767-899E-3C333A27F7E9Q40476954-914F0EB6-3D61-4379-9AC6-7217F7CE3595Q40669084-B5585811-2541-46BC-B5AC-90BE72278E47Q40829514-6B43DCF9-68B3-48AE-9F2D-F0DA299C942CQ41240640-41EBB542-FDAD-415B-A56C-E57450B10B7EQ42060862-921D2590-3E8F-4DD5-8DCF-56CDD5047C5BQ46820934-08EF69CE-1C89-4A79-B62A-13B3833FAE5AQ50954481-3C567632-241A-400E-8914-928814DDC3AF
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Generic substitutions for antiepileptic drugs.
@en
Generic substitutions for antiepileptic drugs.
@nl
type
label
Generic substitutions for antiepileptic drugs.
@en
Generic substitutions for antiepileptic drugs.
@nl
prefLabel
Generic substitutions for antiepileptic drugs.
@en
Generic substitutions for antiepileptic drugs.
@nl
P2093
P356
P1433
P1476
Generic substitutions for antiepileptic drugs.
@en
P2093
Dreifuss FE
Engel J Jr
Mattson RH
Treiman DM
P304
P356
10.1212/WNL.40.11.1647
P407
P577
1990-11-01T00:00:00Z